Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Open-label, Single-arm, Extension Study to Assess Long-term Safety of Evolocumab Therapy in Patients With Clinically Evident Cardiovascular Disease

NCT02867813 is registered in ClinicalTrials.gov with Amgen as lead sponsor.

NCT NCT02867813
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02867813 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Open-label, Single-arm, Extension Study to Assess Long-term Safety of Evolocumab Therapy in Patients With Clinically Evident Cardiovascular Disease
Lead sponsor
Amgen
Phase
Phase 3
Overall status
Completed
Start date
September 2, 2016
Completion date
March 21, 2022
Enrollment
5,035 (actual)
Sites
198

Conditions

As the registry lists them; a condition with its own page is linked.

dyslipidemia